Literature DB >> 2146496

Responses of intercostal muscle biopsies from normal subjects and patients with myasthenia gravis.

M K Pagala1, N V Nandakumar, S A Venkatachari, K Ravindran, T Namba, D Grob.   

Abstract

In order to evaluate the mechanisms of weakness in muscles of patients with myasthenia gravis (MG), intercostal muscle biopsies were obtained from 9 normal subjects and 6 MG patients, and the compound muscle action potential (AP) and tension responses to nerve and muscle stimulation, and contracture responses on exposure to caffeine, were monitored in vitro. In normal muscle, on stimulation of the nerve or muscle at 30 to 100 Hz, the AP responses showed decrement in amplitude, one-third of which was attributable to failure of neuromuscular transmission and two-thirds to failure of muscle membrane excitation. On stimulation at 1 to 5 Hz, the AP responses showed very little decrement, while the contractile responses showed significant fade in tension, due to failure of E-C coupling or contractility. In muscle from patients with generalized MG, stimulation of the nerve at all frequencies (1 to 100 Hz) caused much greater decrement in APs and fade in tension responses than in normal muscle, due mainly to failure of neuromuscular transmission. However, at 100 Hz, 40% of the decrement in APs was due to failure of muscle membrane excitation, and at 1 to 5 Hz, 40% of the fade in tension was due to failure of E-C coupling or contractility, as in normal muscle. On direct stimulation the contraction and half-relaxation times were slower and the tetanic tension was smaller than in normal muscle, especially in the MG patient with thymoma. Caffeine-induced contractures were smaller in MG muscle than in normal muscle. These results indicate that while the weakness of MG muscle is due mainly to failure of neuromuscular transmission, it is also partly due to reduced E-C coupling or contractility.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2146496     DOI: 10.1002/mus.880131103

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  4 in total

1.  Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.

Authors:  A Mygland; J A Aarli; R Matre; N E Gilhus
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-07       Impact factor: 10.154

2.  Breathing pattern and central ventilatory drive in mild and moderate generalised myasthenia gravis.

Authors:  F García Río; C Prados; E Díez Tejedor; S Díaz Lobato; R Alvarez-Sala; J Villamor; J M Pino
Journal:  Thorax       Date:  1994-07       Impact factor: 9.139

3.  Thymoma in myasthenia gravis: from diagnosis to treatment.

Authors:  Fredrik Romi
Journal:  Autoimmune Dis       Date:  2011-08-10

4.  Isozymes of AMP-Deaminase in Muscles Myasthenia Gravis Patients.

Authors:  Iwona M Rybakowska; Stanisław Bakuła; Krystian Kaletha
Journal:  Int J Pept Res Ther       Date:  2016-05-13       Impact factor: 1.931

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.